European mold maker IGS GeboJagema launches US subsidiary

IGS GeboJagema designs, manufactures, and validates high-precision molds for applications such as contact lenses, asthma inhalers, insulin pens, and blood-diagnostic devices. Over the past two decades, the Dutch company has become a strategic partner for large OEMs and top healthcare companies worldwide. The key, according to CEO Peter Mertens, is IGS GeboJagema’s unrivalled engineering expertise combined with their experience working closely with medical OEMs early in the product life cycle.

“Based in the heart of the most prominent technology hub of Europe, we have been able to assemble a team of world-class engineers,” Mertens explains. “Through their ambition and creativity, we develop cutting-edge and highly reliable molding solutions that give our clients an edge over their competitors.”

© IGS GeboJagema | https://www.igsgebojagema.nl

Thanks to the company’s focus on innovation, more and more leading industry players rely on the company’s engineering power in the development of new OEM products.

“To give an example, we are currently involved in all major strategic insulin pen projects,” Mertens says. “We like to partner with our clients as early as possible, so we can make the biggest impact. Whether it’s product design, or a smart mold solution that no one else can offer, we optimize every aspect of the manufacturing process to realize the lowest Total Cost of Ownership possible.”

One major player in the healthcare market states: “IGS GeboJagema has enabled our business to grow 10x over the past 25 years.” They specifically point to the Dutch company’s drive to innovate as having made the difference. “We would not have been successful if IGS had simply delivered the common, standard fare goods. The suite of mold hardware we developed together reduces costs, improves delivery time, and requires less maintenance and toolroom support. Our IGS molds are considered the gold standard within our company’s manufacturing arena.”

IGS GeboJagema’s US subsidiary will be based in Washington D.C. Initially, it will focus on providing faster and more convenient sales and service support to the company’s North-American client base. IGS GeboJagema USA will be launched at MD&M East on December 7, where the company will exhibit at booth 746.